Patents by Inventor Filiberto Cedeno Laurent

Filiberto Cedeno Laurent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Galectin-Immunoglobulin Chimeric Molecules
    Publication number: 20140171621
    Abstract: Described are Galectin-1/Ig fusion constructs and methods of use thereof, e.g., in diagnostic and biomedical assays, and as therapeutic agents for the treatment of conditions associated with immune dysfunction, e.g., autoimmune diseases, and cancers.
    Type: Application
    Filed: December 2, 2013
    Publication date: June 19, 2014
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Charles J. Dimitroff, Filiberto Cedeno Laurent, Steven R. Barthel
  • Galectin-immunoglobulin chimeric molecules
    Patent number: 8598323
    Abstract: Described are Galectin-1/Ig fusion constructs and methods of use thereof, e.g., in diagnostic and biomedical assays, and as therapeutic agents for the treatment of conditions associated with immune dysfunction, e.g., autoimmune diseases, and cancers.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: December 3, 2013
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Charles J. Dimitroff, Filiberto Cedeno Laurent, Steven R. Barthel
  • Galectin-Immunoglobulin Chimeric Molecules
    Publication number: 20120171205
    Abstract: Described are Galectin-1/Ig fusion constructs and methods of use thereof, e.g., in diagnostic and biomedical assays, and as therapeutic agents for the treatment of conditions associated with immune dysfunction, e.g., autoimmune diseases, and cancers.
    Type: Application
    Filed: June 22, 2010
    Publication date: July 5, 2012
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Charles J. Dimitroff, Filiberto Cedeno Laurent, Steven R. Barthel